| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | transcription elongation factor complex | 1.55e-04 | 56 | 39 | 3 | GO:0008023 | |
| Domain | DUF4599 | 2.91e-04 | 12 | 40 | 2 | PF15371 | |
| Domain | DUF4599 | 2.91e-04 | 12 | 40 | 2 | IPR027970 | |
| Domain | Homeobox | 1.54e-03 | 234 | 40 | 4 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.59e-03 | 236 | 40 | 4 | PS00027 | |
| Domain | HOX | 1.61e-03 | 237 | 40 | 4 | SM00389 | |
| Domain | Homeobox_dom | 1.66e-03 | 239 | 40 | 4 | IPR001356 | |
| Domain | HOMEOBOX_2 | 1.66e-03 | 239 | 40 | 4 | PS50071 | |
| Domain | - | 3.07e-03 | 283 | 40 | 4 | 1.10.10.60 | |
| Domain | WW | 4.55e-03 | 47 | 40 | 2 | PF00397 | |
| Domain | WW | 4.74e-03 | 48 | 40 | 2 | SM00456 | |
| Domain | WW_DOMAIN_2 | 5.34e-03 | 51 | 40 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 5.34e-03 | 51 | 40 | 2 | PS01159 | |
| Domain | Homeodomain-like | 5.41e-03 | 332 | 40 | 4 | IPR009057 | |
| Domain | WW_dom | 5.54e-03 | 52 | 40 | 2 | IPR001202 | |
| Domain | Homeobox_CS | 7.33e-03 | 186 | 40 | 3 | IPR017970 | |
| Domain | - | 9.54e-03 | 391 | 40 | 4 | 2.30.29.30 | |
| Domain | PH_dom-like | 1.28e-02 | 426 | 40 | 4 | IPR011993 | |
| Pubmed | PMS2 or PMS2CL? Characterization of variants detected in the 3' of the PMS2 gene. | 1.42e-06 | 2 | 42 | 2 | 37534630 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 30819139 | ||
| Pubmed | Reclassification of a frequent African-origin variant from PMS2 to the pseudogene PMS2CL. | 1.42e-06 | 2 | 42 | 2 | 31916644 | |
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 15256438 | ||
| Pubmed | 4.27e-06 | 3 | 42 | 2 | 10478845 | ||
| Pubmed | Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. | 4.27e-06 | 3 | 42 | 2 | 19039140 | |
| Pubmed | 5.25e-06 | 28 | 42 | 3 | 32868762 | ||
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 23812098 | ||
| Pubmed | Lgl1 Is Required for Olfaction and Development of Olfactory Bulb in Mice. | 8.53e-06 | 4 | 42 | 2 | 27603780 | |
| Pubmed | 9.09e-06 | 407 | 42 | 6 | 12693553 | ||
| Pubmed | Differential expression of alpha-E-catenin and alpha-N-catenin in the developing cerebral cortex. | 1.42e-05 | 5 | 42 | 2 | 16457793 | |
| Pubmed | A Distinct Inhibitory Function for miR-18a in Th17 Cell Differentiation. | 1.42e-05 | 5 | 42 | 2 | 28607111 | |
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 8855241 | ||
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 9286595 | ||
| Pubmed | Dynamic spatiotemporal gene expression in embryonic mouse thalamus. | 1.69e-05 | 41 | 42 | 3 | 21192082 | |
| Pubmed | Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. | 3.68e-05 | 53 | 42 | 3 | 23535033 | |
| Pubmed | 3.97e-05 | 8 | 42 | 2 | 27582690 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 4.63e-05 | 544 | 42 | 6 | 28473536 | |
| Pubmed | 5.10e-05 | 9 | 42 | 2 | 24565118 | ||
| Pubmed | 6.37e-05 | 10 | 42 | 2 | 19321785 | ||
| Pubmed | 6.37e-05 | 10 | 42 | 2 | 16691566 | ||
| Pubmed | Neural stem cell self-renewal requires the Mrj co-chaperone. | 7.78e-05 | 11 | 42 | 2 | 19777589 | |
| Pubmed | 7.78e-05 | 11 | 42 | 2 | 20471949 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 8.92e-05 | 377 | 42 | 5 | 38117590 | |
| Pubmed | 9.32e-05 | 12 | 42 | 2 | 24475213 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 9.82e-05 | 908 | 42 | 7 | 19274049 | |
| Pubmed | 1.10e-04 | 13 | 42 | 2 | 35017475 | ||
| Pubmed | Transcriptional and posttranscriptional regulation of HIV-1 gene expression. | 1.10e-04 | 13 | 42 | 2 | 22355797 | |
| Pubmed | 1.28e-04 | 14 | 42 | 2 | 20854876 | ||
| Pubmed | 1.28e-04 | 14 | 42 | 2 | 16476661 | ||
| Pubmed | 1.28e-04 | 14 | 42 | 2 | 24101523 | ||
| Pubmed | Differential regulation of telencephalic pallial-subpallial boundary patterning by Pax6 and Gsh2. | 1.28e-04 | 14 | 42 | 2 | 18701439 | |
| Pubmed | 1.28e-04 | 14 | 42 | 2 | 25921070 | ||
| Pubmed | 1.28e-04 | 14 | 42 | 2 | 28232627 | ||
| Pubmed | 1.28e-04 | 14 | 42 | 2 | 26728556 | ||
| Pubmed | 1.48e-04 | 15 | 42 | 2 | 19464179 | ||
| Pubmed | 1.48e-04 | 15 | 42 | 2 | 35470378 | ||
| Pubmed | Tbx6-dependent Sox2 regulation determines neural or mesodermal fate in axial stem cells. | 1.48e-04 | 15 | 42 | 2 | 21331042 | |
| Pubmed | Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo. | 1.69e-04 | 16 | 42 | 2 | 22069191 | |
| Pubmed | 1.80e-04 | 233 | 42 | 4 | 37704626 | ||
| Pubmed | 1.85e-04 | 441 | 42 | 5 | 12853948 | ||
| Pubmed | Nova2 regulates neuronal migration through an RNA switch in disabled-1 signaling. | 1.91e-04 | 17 | 42 | 2 | 20620871 | |
| Pubmed | 1.91e-04 | 17 | 42 | 2 | 17626057 | ||
| Pubmed | 1.91e-04 | 17 | 42 | 2 | 19183483 | ||
| Pubmed | 2.15e-04 | 18 | 42 | 2 | 14687547 | ||
| Pubmed | 2.39e-04 | 1049 | 42 | 7 | 27880917 | ||
| Pubmed | alphaE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway. | 2.40e-04 | 19 | 42 | 2 | 16543460 | |
| Pubmed | Lunatic fringe potentiates Notch signaling in the developing brain. | 2.40e-04 | 19 | 42 | 2 | 20510365 | |
| Pubmed | 2.53e-04 | 472 | 42 | 5 | 38943005 | ||
| Pubmed | 2.67e-04 | 20 | 42 | 2 | 16774995 | ||
| Pubmed | 2.67e-04 | 20 | 42 | 2 | 19668339 | ||
| Pubmed | 2.67e-04 | 20 | 42 | 2 | 28154153 | ||
| Pubmed | 2.67e-04 | 20 | 42 | 2 | 34220450 | ||
| Pubmed | 2.95e-04 | 21 | 42 | 2 | 20692344 | ||
| Pubmed | 3.22e-04 | 777 | 42 | 6 | 35844135 | ||
| Pubmed | 3.23e-04 | 110 | 42 | 3 | 27889896 | ||
| Pubmed | Independent regulation of vertebral number and vertebral identity by microRNA-196 paralogs. | 3.24e-04 | 22 | 42 | 2 | 26283362 | |
| Pubmed | The Role of RNA Polymerase II Elongation Control in HIV-1 Gene Expression, Replication, and Latency. | 3.24e-04 | 22 | 42 | 2 | 22567366 | |
| Pubmed | 3.54e-04 | 23 | 42 | 2 | 19737349 | ||
| Pubmed | Primary cilia regulate hippocampal neurogenesis by mediating sonic hedgehog signaling. | 3.54e-04 | 23 | 42 | 2 | 18728187 | |
| Pubmed | 3.86e-04 | 24 | 42 | 2 | 20237272 | ||
| Pubmed | Gene network analysis in a pediatric cohort identifies novel lung function genes. | 3.86e-04 | 24 | 42 | 2 | 24023788 | |
| Pubmed | Presenilin 1 in migration and morphogenesis in the central nervous system. | 4.20e-04 | 25 | 42 | 2 | 15163631 | |
| Pubmed | Sp8 controls the anteroposterior patterning at the midbrain-hindbrain border. | 4.20e-04 | 25 | 42 | 2 | 16571633 | |
| Pubmed | 4.54e-04 | 26 | 42 | 2 | 19060336 | ||
| Pubmed | Olig1 function is required to repress dlx1/2 and interneuron production in Mammalian brain. | 4.54e-04 | 26 | 42 | 2 | 24507192 | |
| Pubmed | Cerebellar dysfunction and schizophrenia-like behavior in Ebp1-deficient mice. | 4.54e-04 | 26 | 42 | 2 | 35165395 | |
| Pubmed | Compartment-dependent activities of Wnt3a/β-catenin signaling during vertebrate axial extension. | 4.90e-04 | 27 | 42 | 2 | 25152336 | |
| Pubmed | Specification of jaw identity by the Hand2 transcription factor. | 5.28e-04 | 28 | 42 | 2 | 27329940 | |
| Pubmed | ISL1 is necessary for auditory neuron development and contributes toward tonotopic organization. | 5.28e-04 | 28 | 42 | 2 | 36074819 | |
| Pubmed | 5.51e-04 | 132 | 42 | 3 | 34321664 | ||
| Pubmed | 6.06e-04 | 30 | 42 | 2 | 25804738 | ||
| Pubmed | 6.47e-04 | 31 | 42 | 2 | 36476860 | ||
| Pubmed | 6.81e-04 | 142 | 42 | 3 | 30232004 | ||
| Pubmed | 6.90e-04 | 32 | 42 | 2 | 38110169 | ||
| Pubmed | Mind bomb 1 is essential for generating functional Notch ligands to activate Notch. | 7.34e-04 | 33 | 42 | 2 | 16000382 | |
| Pubmed | 9.65e-04 | 634 | 42 | 5 | 34591612 | ||
| Pubmed | Defining the molecular character of the developing and adult kidney podocyte. | 1.03e-03 | 39 | 42 | 2 | 21931791 | |
| Pubmed | 1.03e-03 | 39 | 42 | 2 | 22802532 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 1.08e-03 | 40 | 42 | 2 | 34585037 | |
| Pubmed | 1.08e-03 | 40 | 42 | 2 | 21256124 | ||
| Pubmed | A genome-wide search for common SNP x SNP interactions on the risk of venous thrombosis. | 1.13e-03 | 41 | 42 | 2 | 23509962 | |
| Pubmed | 1.13e-03 | 41 | 42 | 2 | 25452572 | ||
| Pubmed | 1.20e-03 | 173 | 42 | 3 | 23979707 | ||
| Cytoband | 9q21.32 | 1.38e-04 | 19 | 42 | 2 | 9q21.32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 2.57e-04 | 134 | 42 | 3 | chr7p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p22 | 8.60e-04 | 47 | 42 | 2 | chr8p22 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 8.88e-03 | 92 | 28 | 2 | 521 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.25e-02 | 110 | 28 | 2 | 420 | |
| Coexpression | ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF | 1.35e-06 | 232 | 40 | 6 | M2613 | |
| Coexpression | GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP | 1.27e-05 | 199 | 40 | 5 | M3046 | |
| Coexpression | LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B | 1.84e-05 | 103 | 40 | 4 | M39240 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29 | 6.32e-05 | 8 | 40 | 2 | M762 | |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 8.19e-05 | 294 | 40 | 5 | M41112 | |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 1.24e-04 | 168 | 40 | 4 | M6874 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 1.27e-04 | 169 | 40 | 4 | M39230 | |
| Coexpression | MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP | 1.54e-04 | 68 | 40 | 3 | M11763 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_UP | 2.38e-04 | 199 | 40 | 4 | M8002 | |
| Coexpression | GSE17721_CTRL_VS_CPG_4H_BMDC_DN | 2.42e-04 | 200 | 40 | 4 | M3763 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN | 2.42e-04 | 200 | 40 | 4 | M3779 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN | 2.42e-04 | 200 | 40 | 4 | M5529 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 2.42e-04 | 200 | 40 | 4 | M8088 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | 2.42e-04 | 200 | 40 | 4 | M7841 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.84e-05 | 167 | 42 | 4 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.84e-05 | 167 | 42 | 4 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 170 | 42 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_GRIP2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-05 | 175 | 42 | 4 | 0c648e7f67ffbe3b476a2ca77d246554f8cd1882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.37e-05 | 195 | 42 | 4 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Meis2-Meis2_Adamts19|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.63e-05 | 68 | 42 | 3 | 3a61ea2b234829632fabede72761aa6664550e56 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Meis2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.63e-05 | 68 | 42 | 3 | 3c5d0d35e4d1c5506a4a490e2f93e8024294207f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 3.64e-05 | 199 | 42 | 4 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 199 | 42 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 3.64e-05 | 199 | 42 | 4 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| Disease | urate measurement, bone density | 1.30e-04 | 619 | 38 | 6 | EFO_0003923, EFO_0004531 | |
| Disease | cystathionine measurement | 2.72e-04 | 19 | 38 | 2 | EFO_0010474 | |
| Disease | Alzheimer disease, APOE carrier status | 2.75e-04 | 98 | 38 | 3 | EFO_0007659, MONDO_0004975 | |
| Disease | sex interaction measurement, bilirubin measurement | 3.67e-04 | 22 | 38 | 2 | EFO_0004570, EFO_0008343 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 3.97e-04 | 111 | 38 | 3 | EFO_0004530, EFO_0008595 | |
| Disease | immature platelet fraction | 4.29e-04 | 114 | 38 | 3 | EFO_0009187 | |
| Disease | age at menopause | 6.04e-04 | 302 | 38 | 4 | EFO_0004704 | |
| Disease | C-reactive protein measurement | 7.77e-04 | 1206 | 38 | 7 | EFO_0004458 | |
| Disease | Stuttering | 8.30e-04 | 143 | 38 | 3 | HP_0025268 | |
| Disease | triglyceride measurement, physical activity | 8.83e-04 | 34 | 38 | 2 | EFO_0003940, EFO_0004530 | |
| Disease | multiple sclerosis | 9.42e-04 | 594 | 38 | 5 | MONDO_0005301 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.01e-03 | 153 | 38 | 3 | EFO_0004611, EFO_0020946 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.28e-03 | 166 | 38 | 3 | EFO_0004530, EFO_0004611 | |
| Disease | ejection fraction measurement | 1.41e-03 | 43 | 38 | 2 | EFO_0005527 | |
| Disease | Abnormality of refraction | 1.64e-03 | 673 | 38 | 5 | HP_0000539 | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 1.68e-03 | 47 | 38 | 2 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | breast carcinoma | 1.79e-03 | 1019 | 38 | 6 | EFO_0000305 | |
| Disease | response to trauma exposure | 1.98e-03 | 51 | 38 | 2 | EFO_0008483 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 1.98e-03 | 51 | 38 | 2 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 1.98e-03 | 51 | 38 | 2 | EFO_0022240 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 2.14e-03 | 53 | 38 | 2 | EFO_0022286 | |
| Disease | triglycerides in very large HDL measurement | 2.30e-03 | 55 | 38 | 2 | EFO_0022324 | |
| Disease | fatty acid measurement | 2.33e-03 | 436 | 38 | 4 | EFO_0005110 | |
| Disease | triglycerides in LDL measurement | 2.38e-03 | 56 | 38 | 2 | EFO_0022320 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 2.38e-03 | 56 | 38 | 2 | EFO_0022316 | |
| Disease | triglycerides in IDL measurement | 2.55e-03 | 58 | 38 | 2 | EFO_0022149 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.55e-03 | 447 | 38 | 4 | EFO_0000694, MONDO_0100096 | |
| Disease | triglycerides to total lipids in small LDL percentage | 2.64e-03 | 59 | 38 | 2 | EFO_0022337 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 2.64e-03 | 59 | 38 | 2 | EFO_0022248 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 2.64e-03 | 59 | 38 | 2 | EFO_0022260 | |
| Disease | basophil measurement | 2.73e-03 | 60 | 38 | 2 | EFO_0803539 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 2.73e-03 | 60 | 38 | 2 | EFO_0021898 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.85e-03 | 220 | 38 | 3 | EFO_0004529, EFO_0008317 | |
| Disease | triglycerides in medium LDL measurement | 2.91e-03 | 62 | 38 | 2 | EFO_0022322 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 2.91e-03 | 62 | 38 | 2 | EFO_0022306 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 2.91e-03 | 62 | 38 | 2 | EFO_0022263 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 3.00e-03 | 63 | 38 | 2 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 3.00e-03 | 63 | 38 | 2 | EFO_0022292 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.19e-03 | 229 | 38 | 3 | EFO_0004639, EFO_0008317 | |
| Disease | triglycerides in small LDL measurement | 3.19e-03 | 65 | 38 | 2 | EFO_0022323 | |
| Disease | Bipolar Disorder | 3.22e-03 | 477 | 38 | 4 | C0005586 | |
| Disease | Alzheimer disease | 3.42e-03 | 485 | 38 | 4 | MONDO_0004975 | |
| Disease | smoking status measurement | 3.42e-03 | 1160 | 38 | 6 | EFO_0006527 | |
| Disease | triglycerides in very small VLDL measurement | 3.49e-03 | 68 | 38 | 2 | EFO_0022144 | |
| Disease | Nonorganic psychosis | 3.59e-03 | 69 | 38 | 2 | C0349204 | |
| Disease | basophil percentage of leukocytes | 3.76e-03 | 243 | 38 | 3 | EFO_0007992 | |
| Disease | mean arterial pressure | 3.78e-03 | 499 | 38 | 4 | EFO_0006340 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PDHGGGEDSCAKTDT | 71 | Q7Z3E2 | |
| SSSDEGSGKSKHSSP | 536 | O60583 | |
| GSSSGGSKHSADGIP | 581 | O60583 | |
| ASPSEKGAHPSGGAD | 16 | Q07065 | |
| KYGGDSDHPSDGETS | 266 | Q8WYQ5 | |
| DVAGSDSSHKDGPCG | 471 | O60393 | |
| PESSEHEDKSAGASG | 251 | Q86UL8 | |
| SGGEHAPSEDSGKDR | 636 | Q9Y216 | |
| KEGADPHTLVSSGGS | 81 | Q9Y6X6 | |
| ADTLGTAHSPKDGSS | 631 | Q9H1B7 | |
| GSGEGGNAIKDHSSS | 471 | A6NKB5 | |
| KSGAEGDDTGAPHSP | 1111 | Q6AI08 | |
| SPDHSSLEAKDGESG | 471 | P48681 | |
| SPESSSGHTEDKAGG | 221 | P31270 | |
| GGGPTEQDKSHSNSS | 351 | Q2PPJ7 | |
| GTGKGSQDHSGDPTS | 246 | Q96JZ2 | |
| DHSGATATGGASELK | 336 | P55317 | |
| GSSSEKEGSEDEHSG | 401 | Q8N7H5 | |
| GSSHTSGVESGGKDR | 431 | Q96NE9 | |
| KDEDTTSHSSSKGGG | 161 | Q96BY6 | |
| TSPTDEAKGHTGIGE | 261 | P26232 | |
| GSAHSSGSTSEKPEE | 536 | O60266 | |
| SSGEDSKSHIPGSET | 2051 | Q9NSI6 | |
| DTHGTLGSGRSSDKG | 16 | Q96L34 | |
| LESTSDLGASGKHGG | 2081 | Q8TEP8 | |
| GSGDSDSESDHTAPS | 571 | P54792 | |
| KTPGAGESSEDNSDH | 131 | Q8IUI4 | |
| LHGEGSSSGKATGDE | 231 | P61247 | |
| SAHSDPESLGGTDTK | 16 | Q02577 | |
| DGNPSTEDESSKGHE | 291 | Q9UIU6 | |
| GGSSTSAPTTKGIDH | 331 | Q6ZUB0 | |
| STSSSPGKEGHSPEG | 271 | O75381 | |
| KGSDTDSEHSAAGSP | 456 | Q8IXZ3 | |
| SFGGETSNSGDPHKG | 66 | O75969 | |
| KGSRSSSEHKGSSGD | 921 | P51825 | |
| KDSTGSLPGSGSTHG | 666 | Q15596 | |
| GGSSTSAPTTKGIDH | 331 | P0C874 | |
| GHTPEGSKADSAVSS | 206 | P35398 | |
| EKDSGHGSTSVDSEG | 491 | P54278 | |
| KDSGHGSTSVDSEGF | 106 | Q68D20 | |
| GSGKSNVGTSGDHDD | 111 | Q6S545 | |
| SEGKAPDTSDHGGST | 36 | Q9NYI0 | |
| SLHSAPSSDSDSGGG | 226 | A6NJT0 |